All articles

Never say never

March 2019|When Becky Furuta was told her cycling career was over, she defied doctors' orders to rise to the top of her profession.

Listen to the podcast 


The technology behind tablets

February 2019|What if medicines injected by millions could be delivered in tablets? Our CSO Mads Krogsgaard Thomsen looks to the future.

Learn more


Obesity – The brain is the battleground

October 2018|Our head of obesity research, Mads Tang-Christensen, explains the brain’s role in the struggle to lose weight.

Learn more


Towards a cure for type 1 diabetes

August 2018|Jacob Sten Petersen is working to cure type 1 diabetes, a disease his five-year-old daughter Vita lives with.

Hear their story


Through the lens: portraits of diabetes in the developing world

June 2018|Photographer Jesper Westley captures the many faces of the global diabetes pandemic.

See the portraits
 


The exciting potential of stem cell research

May 2018|Mads Krogsgaard Thomsen, CSO of Novo Nordisk, considers the potential of stem cell-based therapies to cure type 1 diabetes and other chronic diseases

Read Mads’ perspective
 


Why we must do more to tackle chronic disease in humanitarian crises

April 2018|CEO, Lars Fruergaard Jørgensen, reflects on the challenge of providing access to care among vulnerable populations displaced by conflict

Driving access to care for refugees
 


Including the excluded

April 2018|Meet Alvin Moustgaard, one of seven colleagues in our employment programme for people living with autism spectrum disorder.

Including autistic people in the workforce
 


Mother of molecules

February 2018|Lotte Bjerre Knudsen, Scientific Vice President at Novo Nordisk, discovered the molecule liraglutide and oversaw its journey from “underdog candidate” to a treatment for more than a million people with diabetes and obesity.

Listen to the podcast

 


The pursuit of oral insulin

December 2017|Novo Nordisk Chief science officer Mads Krogsgaard Thomsen reflects on the past, present and future of insulin in a tablet.

Oral insulin remains the ‘Holy Grail’ of diabetes
 


It’s time we changed the conversation about obesity

November 2017|President and chief executive officer of Novo Nordisk, Lars Fruergaard Jørgensen on why the definition of obesity is just the beginning of a broader, more significant discussion.

Changing the conversation about obesity
 


From the heart

September 2017|Simone, an employee of Novo Nordisk, reflects on her perpetual battles with type 2 diabetes, heart disease and stigmatisation.

Life with type 2 diabetes together with heart disease
 


New beginnings

September 2017|With millions displaced by war, business has a key role in helping refugees integrate, contribute and flourish in society.

Our role in helping refugees integrate and contribute
 


With a little help from our peers

September 2017|Can your peers help prevent type 2 diabetes? Henriette Curtz Jansen from Copenhagen municipality thinks so and shares how peer networks have been successful in Denmark.

Type 2 diabetes networks in Copenhagen


Subscribe to Perspectives

Explore features and points of view from Novo Nordisk
and the society we serve.